Sept. 14-16 2017
Washington, DC area
October 8-11, 2017
Omicia, Inc. today announced that four new world-renowned clinical and genomic scientists will advise the strategic development of Omicia’s clinical diagnostic genome interpretation software, and support the company’s vision of improved patient care through personalized medicine.
Omicia, Inc. today announced that Omicia’s clinical next-generation sequencing (NGS) interpretation software will be used by LabCorp for its clinical trials sequencing services.